Kim et al. (2024) illustrated that P. g-OMVs enhance liver steatosis in mice on a low-fat diet by modulating the plasminogen activator inhibitor-1 (PAI-1)/TLR2 axis. Here, SERPINE1 is linked to fatty liver disease.